ImCheck Therapeutics
FranceWho owns ImCheck Therapeutics?
ImCheck Therapeutics was owned by Earlybird Venture Capital through Earlybird Health (2017 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, ImCheck Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Key facts
- ·Fully exited in 2025.
- ·Average hold across 3 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from Earlybird Health
Other portfolio companies in the same fund.
UK
Switzerland
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy ImCheck Therapeutics?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on ImCheck Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in